Ongoing support for appetite regulation and metabolic balance.
A once-weekly compounded injectable form of Semaglutide that may be prescribed by a licensed provider to support glucose metabolism, appetite balance, and overall metabolic health as part of a personalized care plan.
This therapy is offered as a compounded prescription for eligible patients, supporting a more modern, clinician-guided approach to individualized metabolic care.
Who is it for?Semaglutide Injectable may be appropriate for adults who are evaluated by a licensed healthcare provider and determined to be candidates for provider-supervised metabolic care.
It is not appropriate for everyone, including individuals who are pregnant or breastfeeding, or those with certain medical conditions. Eligibility is determined through clinical evaluation, and not all patients will qualify.
These benefits reflect known findings on the formula’s key ingredients. Results for individual patients may vary.
Support for long-term metabolic wellness and insulin sensitivity.
Metformin is a prescription oral medication with decades of clinical use and is commonly prescribed by providers as part of long-term metabolic care. When compounded, it may be prepared in tailored strengths or extended-release formats, allowing providers to personalize dosing based on individual needs and tolerability.
Foundational support for everyday energy and nervous system health.
B12 is a compounded injectable form of vitamin B12, an essential nutrient involved in cellular metabolism and nervous system function. It may be prescribed by a licensed provider based on your health history and care needs.
Semaglutide is a prescription medication that helps regulate appetite, blood sugar, and digestion to support weight management and metabolic health.
What is Semaglutide commonly used for?Semaglutide may be prescribed to support:
Metabolic health
Brand-name Semaglutide medications are FDA-approved for certain indications. Compounded Semaglutide is not FDA-approved but is prepared by licensed compounding pharmacies under regulatory standards.
Who might be a good candidate for Semaglutide Injectable therapy?Semaglutide may be considered for adults who meet certain clinical criteria related to weight management or metabolic health. A provider will review your medical history and health goals to determine whether treatment is appropriate.
When will I notice results?Some patients notice appetite reduction within the first 1–2 weeks. Weight loss typically occurs gradually and may increase as doses are titrated.
What are common side effects?Common side effects may include:
These effects often improve as the body adjusts to treatment.
How long do patients typically use Semaglutide?Duration of use varies depending on individual goals, response, and provider guidance. Some patients continue treatment long-term, while others transition to maintenance strategies.
Compounded medications are not FDA-approved. Compounded GLP-1s are prepared by licensed pharmacies for patients with a valid prescription when an FDA-approved medication is not medically appropriate. Eligibility for compounded GLP-1 medications is determined by a licensed healthcare provider who will determine if such medications are medically appropriate given your medical history and clinical evaluation. Not all patients will qualify for a compounded GLP-1 medication. KINSYN provides clinician-guided wellness and metabolic health programs. This information is educational and not medical advice.